3419 related articles for article (PubMed ID: 15322536)
1. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
Curiel TJ; Coukos G; Zou L; Alvarez X; Cheng P; Mottram P; Evdemon-Hogan M; Conejo-Garcia JR; Zhang L; Burow M; Zhu Y; Wei S; Kryczek I; Daniel B; Gordon A; Myers L; Lackner A; Disis ML; Knutson KL; Chen L; Zou W
Nat Med; 2004 Sep; 10(9):942-9. PubMed ID: 15322536
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.
Lee I; Wang L; Wells AD; Dorf ME; Ozkaynak E; Hancock WW
J Exp Med; 2005 Apr; 201(7):1037-44. PubMed ID: 15809349
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
4. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
Casares N; Arribillaga L; Sarobe P; Dotor J; Lopez-Diaz de Cerio A; Melero I; Prieto J; Borrás-Cuesta F; Lasarte JJ
J Immunol; 2003 Dec; 171(11):5931-9. PubMed ID: 14634104
[TBL] [Abstract][Full Text] [Related]
5. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.
Ishida T; Ishii T; Inagaki A; Yano H; Komatsu H; Iida S; Inagaki H; Ueda R
Cancer Res; 2006 Jun; 66(11):5716-22. PubMed ID: 16740709
[TBL] [Abstract][Full Text] [Related]
6. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
Wei S; Kryczek I; Zou L; Daniel B; Cheng P; Mottram P; Curiel T; Lange A; Zou W
Cancer Res; 2005 Jun; 65(12):5020-6. PubMed ID: 15958543
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and functional characterization of freshly isolated and expanded canine regulatory T cells.
Knueppel A; Lange S; Sekora A; Altmann S; Freund M; Junghanss C
Exp Anim; 2011; 60(5):471-9. PubMed ID: 22041284
[TBL] [Abstract][Full Text] [Related]
9. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
[TBL] [Abstract][Full Text] [Related]
10. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
Roncarolo MG; Gregori S; Levings M
Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
[TBL] [Abstract][Full Text] [Related]
11. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.
Zhang H; Chua KS; Guimond M; Kapoor V; Brown MV; Fleisher TA; Long LM; Bernstein D; Hill BJ; Douek DC; Berzofsky JA; Carter CS; Read EJ; Helman LJ; Mackall CL
Nat Med; 2005 Nov; 11(11):1238-43. PubMed ID: 16227988
[TBL] [Abstract][Full Text] [Related]
12. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
[TBL] [Abstract][Full Text] [Related]
13. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma.
Enarsson K; Lundgren A; Kindlund B; Hermansson M; Roncador G; Banham AH; Lundin BS; Quiding-Järbrink M
Clin Immunol; 2006 Dec; 121(3):358-68. PubMed ID: 16934529
[TBL] [Abstract][Full Text] [Related]
14. In vivo sites and cellular mechanisms of T reg cell-mediated suppression.
Rudensky AY; Campbell DJ
J Exp Med; 2006 Mar; 203(3):489-92. PubMed ID: 16533888
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.
Baratelli F; Lin Y; Zhu L; Yang SC; Heuzé-Vourc'h N; Zeng G; Reckamp K; Dohadwala M; Sharma S; Dubinett SM
J Immunol; 2005 Aug; 175(3):1483-90. PubMed ID: 16034085
[TBL] [Abstract][Full Text] [Related]
16. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
[TBL] [Abstract][Full Text] [Related]
17. The role of CD4+CD25+ regulatory T cells in viral infections.
Vahlenkamp TW; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):219-25. PubMed ID: 16126280
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.
Bedke T; Pretsch L; Karakhanova S; Enk AH; Mahnke K
J Immunol; 2010 May; 184(10):5562-70. PubMed ID: 20382886
[TBL] [Abstract][Full Text] [Related]
19. Human CD4+CD25+ regulatory T cells.
Baecher-Allan C; Viglietta V; Hafler DA
Semin Immunol; 2004 Apr; 16(2):89-98. PubMed ID: 15036232
[TBL] [Abstract][Full Text] [Related]
20. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
Karakhanova S; Munder M; Schneider M; Bonyhadi M; Ho AD; Goerner M
J Immunother; 2006; 29(3):336-49. PubMed ID: 16699377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
